╌>

A Killer on the Loose- Patients at UCLA were becoming deathly ill. A superbug was spreading. Could doctors stop it?

  

Category:  News & Politics

Via:  dr-trevor-k-johnson  •  11 years ago  •  18 comments

A Killer on the Loose- Patients at UCLA were becoming deathly ill.  A superbug was spreading. Could doctors stop it?

A Killer
on the Loose

Patients at UCLA were becoming deathly ill.
A superbug was spreading. Could doctors stop it?

A long black scope had been threaded down her throat to treat troublesome gallstones. Now antibiotics were powerless to stop a raging infection.

Her physicians called in Dr. Zachary Rubin, the hospitals director of clinical epidemiology and infection prevention, and its top disease detective.

He immediately suspected the scope itself a dirty one could cause this kind of infection.

So Rubin inspected the hospitals cleaning rooms, where workers scrub dozens of reusable medical instruments and load them in washing machines packed with powerful disinfectants. He saw no evidence to support his theory.

800 Dr. Zachary Rubin, head of infection prevention at UCLA. (Al Seib / Los Angeles Times). Lead image above: A rendering by the Centers for Disease Control and Prevention of the CRE superbug. (Getty Images)

He considered taking the devices, known as duodenoscopes, out of service. But if his hunch was wrong, he knew there could be serious consequences.

The scopes, used several times a day at the hospital, save the lives of some critically ill patients and spare them complications from surgery. He held off to keep investigating.

But he didnt realize that the woman wasnt an isolated case. A superbug outbreak was already spreading inside UCLA on that day in mid-December.

A killer was on the loose.

...

The bacteria arrived at UCLA unnoticed in September, hitching a ride on a patient.

Unbeknownst to doctors, that patient a woman being evaluated for a liver transplant was carrying an unusually potent version of CRE, or carbapenem-resistant enterobacteriaceae.

Some Americans carry these bacteria with no ill effects, but years of antibiotic overuse have created virulent strains immune to most treatments. By some estimates, CRE kills up to half of infected patients.

900 The Olympus TJF-Q180V duodenoscope.

The source patient at UCLA underwent a procedure Oct. 3 known as ERCP, or endoscopic retrograde cholangiopancreatography. During the procedure, a flexible scope is used to diagnose and treat problems in the digestive tract such as cancers and blockages in the bile duct. Nearly 700,000 such procedures are performed annually in the U.S. More than 800 are done each year at UCLA, among the most at any hospital nationwide.

The medical scope had picked up the bacteria from the womans intestinal tract, and the standard cleaning didnt remove it.

...

Just two weeks later, in mid-October, Lori Smith called 911 at her modest home in a leafy section of Woodland Hills. Her 18-year-old son, Aaron Young, was doubled over in pain. He couldnt summon the strength to get dressed after his morning shower.

Young landed in the pediatric intensive-care unit at UCLA with an inflamed pancreas. Four days later, a doctor guided a slender scope down his throat to put a tiny stent deep in his gut.

It was the same scope that had been used earlier on the first CRE patient.

Within days, an infection sent Young into septic shock. As his fever hit 104, nurses piled green cooling blankets on his 140-pound body. A ventilator kept him breathing.

900 900 Above: Aaron Young, right, with his brother, Austin and sister Trisha, the weekend before he was hospitalized. Below: Aaron Young in his room at UCLA after first being infected with CRE. (Glenn Smith)

Doctors soon realized he was fighting an antibiotic-resistant superbug. But they had no idea where it came from.

His parents Lori and her husband, Glenn Smith struggled through each day, not knowing whether their son would survive another night. They took turns sleeping on a small couch pushed up against the wall of his fifth-floor room in the ICU.

On her mornings at home, Lori Smith would check her sons latest lab results on her smartphone.

Every day brought a new horror, she said.

The nonstop fever and the cooling blankets, set to 30 degrees, kept Young shivering uncontrollably. His body began shutting down from an untreatable nightmare.

---Continue Reading Article---


Tags

jrDiscussion - desc
[]
 
Chucky Stuart
Freshman Silent
link   Chucky Stuart    11 years ago

Hi Doc. I'm curious; what kinds of treatments are used to fight these antibiotic-resistant superbugs?

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

On Jan. 25, Young was due back at the hospital for another ERCP procedure to remove his stent. He was scheduled to go home five days later.

A doctor put a duodenoscope down Youngs throat for a second time.

They said it would be a walk in the park, said his father, Glenn Smith, a 53-year-old cabinetmaker.

Young crashed again. His temperature spiked to 103. His blood pressure plunged to 60 over 29. His survival was back in doubt.

On the same day Young was scoped, Jan. 27, Rubin and his team started to connect the dots.

800 At left, a patient sample that tested positive for the CRE superbug; at right, a negative sample. (Wally Skalij / Los Angeles Times)

The microbiologists had obtained a detailed genetic fingerprint for one of the CRE cases, and they confirmed that several infected patients were matches. It was only the second time that strain of CRE had been found in the U.S.

More conventional testing methods, such as looking at levels of antibiotic resistance, had given doctors the false impression that patient infections were unrelated. Tiny pieces of DNA were carrying an antibiotic-resistant gene from one cell to another, creating different-looking bugs.

With a cluster of matching cases, Rubin asked a young infectious diseases doctor to look back at when those patients had undergone their scope procedures.

Quen Cheng, on a two-week rotation in infection prevention, dug through computer files at his kitchen table at night.

Rubin was home nursing a bad cold the next day, Jan. 28, when his top deputy texted, telling him to check his email.

He opened a message from Cheng containing a hand-drawn diagram mapping out when every infected patient had been scoped. Cheng scribbled stars across the page showing each persons superbug encounter.

This is it, Rubin said, sitting up in bed and staring at his laptop.

Now he had no doubt. The bug came from dirty scopes.

...

The discovery unleashed a chain reaction inside and outside UCLA.

Doctors had confirmed that the transplant patient, admitted four months earlier in September, had passed the bug onto a scope made by Olympus Corp.

Sitting on the edge of his bed, Rubin called the endoscopy lab and halted ERCP procedures. Next, he alerted L.A. County public health authorities.

The hospital pulled the cleaning logs to determine what scopes were used on the infected patients. Rubin needed a list of all patients who may have been exposed, so they could be notified for testing.

900

One scope, labeled No. 47, was used on most of the infected patients, including the one who brought the bacteria into the hospital in September and Young. Another dirty scope, No. 26, was used on some of them.

Both scopes had been cleaned in accordance with the manufacturers instructions, federal and county health officials said. The $40,000 scopes were just 7 months old.

One of Youngs doctors, Jaime Deville, took his parents down the hospital hallway on Feb. 2 to tell them the news. He swallowed hard and braced himself for the yelling.

Youngs parents, overwhelmed by the information, were speechless. All they could do was return to their sons room and pray over him at his bedside.

The anger came later, Lori Smith said.

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

Great question Mr. Stuart.

Medical professionals take a multitude of approaches, but in the referenced case above, their treatment was described as:

Youngs doctors were experimenting with a cocktail of half a dozen antibiotics to fight his stubborn bacteria. One older drug appeared to work, but it posed severe side effects.

For even more information, I suggest:

Much of the increase in CRE is likely related to the emergence and spread of the genes coding for carbapenemases. In the United States, the most commonly identified carbapenemase is Klebsiella pneumoniae carbapenemase (KPC). This enzyme was first described in 2001 in an isolate obtained from a patient from North Carolina. Other carbapenemases produced by Enterobacteriaceae that have been described in patients hospitalized in the United States include NDM, VIM, IMP, and OXA-48. These non-KPC carbapenemases have primarily been isolated from patients who have received recent healthcare outside of the United States.

Continuing:

CRE Can Be Prevented

Current evidence about the prevalence of CRE suggests that these organisms are still relatively uncommon in many parts of the United States. Aggressive action now has the potential to slow the emergence of these organisms, especially in places where they are still uncommon. The recommendations in the CDC CRE toolkit have been used successfully in many settings to control the spread of these organisms. For example, a hospital in New York reduced CRE by more than 50% by implementing CDC's recommended practices. [3] The country of Israel reduced CRE infection rates in all 27 of its hospitals by more than 70% in 1 year with a coordinated prevention program. [4]

We face myriad challenges in modern healthcare, but what makes this article most disturbing is that the CRE was contracted at UCLA as a result of inadequately sterilized medical instruments, and that quite simply cannot happen. Very disturbing indeed.

 
 
 
Kavika
Professor Expert
link   Kavika     11 years ago

What is the solution to this?

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

What Can Healthcare Professionals Do?

Healthcare providers can help by doing the following:

  • Know if patients in your facility have CRE.
    • Request immediate alerts when the lab identifies CRE.
    • Alert the receiving facility when a patient with CRE transfers out, and find out when a patient with CRE transfers into your facility.
  • Protect your patients from CRE.
    • Follow contact precautions and hand hygiene recommendations when treating patients with CRE.
    • Dedicate rooms, staff, and equipment to patients with CRE.
    • Prescribe antibiotics wisely ( Get Smart for Healthcare ).
    • Remove temporary medical devices such as catheters and ventilators from patients as soon as possible
 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

CRE, which stands for carbapenem-resistant Enterobacteriaceae, are a family of germs that are difficult to treat because they have high levels of resistance to antibiotics.Klebsiellaspecies andEscherichia coli (E. coli)are examples of Enterobacteriaceae, a normal part of the human gut bacteria, that can become carbapenem-resistant.

Types of CRE are sometimes known as KPC (Klebsiella pneumoniaecarbapenemase) and NDM (New Delhi Metallo-beta-lactamase). KPC and NDM are enzymes that break down carbapenems and make them ineffective. Both of these enzymes, as well as the enzyme VIM (Verona Integron-Mediated Metallo--lactamase) have also been reported in Pseudomonas.

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

2012 CRE Toolkit - Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE)

This Toolkit is currently being revised

Carbapenem-resistant Enterobacteriaceae (CRE) are a serious threat to public health. Infections with CRE are difficult, and in some cases impossible, to treat and have been associated with mortality rates up to 50% (1) . Due to the movement of patients throughout the healthcare system, if CRE are a problem in one facility, then typically they are a problem in other facilities in the region as well. To help protect patients and prevent transmission, CDC has released a CRE toolkit which expands on the 2009 CDC recommendations and continues to be updated as new information becomes available.

Table of Contents

 
 
 
Chucky Stuart
Freshman Silent
link   Chucky Stuart    11 years ago

The fact that these bacteria have mutated to the point where they are not only resistant to antibiotics but to normal sterilization procedures as well is very disturbing. I was aware of the former, but this is the first time I have read about the latter.

 
 
 
Kavika
Professor Expert
link   Kavika     11 years ago

Agreed Chucky, I've never heard of anything being resistant to sterilization procedures.

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

ABCNEWS.com

A new superbug is on the rise in U.S. hospitals , according to the U.S. Centers for Disease Control and Prevention. The family of germs, dubbed CRE for carbapenem-resistant Enterobacteriaceae, evades some the strongest antibiotics, making infections almost untreatable.

"Right now, these infections are limited to hospitals, but we know from history that bacteria that start in hospitals often find a way out into the community," said ABC News chief health and medical editor Dr. Richard Besser, who for seven years ran a CDC program aimed at promoting proper antibiotic use to curb antibiotic resistance . "That would be a nightmare scenario."

One in 25 acute-care facilities reported at least one case of hospital-acquired CRE last year, according to the CDC . Most of the infected patients, who tended to have multiple medical problems and weakened immune systems, were treated with colistin, an older antibiotic that can have toxic effects on the kidneys.

"For many patients, that's their only choice," Besser said. "And even with treatment, almost half of all patients who get this infection in their bloodstream die from it."

The CDC has urged hospitals, health care providers and patients to take steps to curb the spread of the dangerous superbug that include frequent hand-washing. The agency also recommends removing intravenous lines and catheters as early as possible to reduce the risk of infection.

"The goal of the campaign is to get this under control right now, before CRE has a chance to spread to more hospitals and out into the community," said Besser.

CRE isn't the only scary superbug. ABC News asked infectious disease experts which antibiotic-resistant bacteria pose the biggest threats at home and abroad.

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

The article continues:

U.S. hospitals received new cleaning instructions for duodenoscopes a month later, in March, from the leading manufacturer, Olympus, which controls 85% of the market. The company also recommended a new cleaning brush.

Olympus had taken similar steps more than two years earlier, in Europe. The company warned European hospitals and doctors in January 2013 that lethal bacteria could become trapped at the tip of its scopes. It had issued no warning in the U.S., however.

800 Olympus Corp. promoted its scopes at a medical conference in Washington, D.C., in May. (Chad Terhune / Los Angeles Times)

Federal prosecutors have issued subpoenas to Olympus and two other scope makers, seeking details about when they knew about the dangers of their devices and what actions they took to safeguard patients.

After investigating previous outbreaks and receiving injury reports, U.S. health officials also were aware of an infection risk from contaminated scopes and had been working on new cleaning standards since 2011.

Its just shocking that so many people were affected by this without anything being done about it, said Lori Smith, Youngs mother and herself a nurse. Does business go on as normal and people keep getting infected?

Food and Drug Administration officials counter that it took time to evaluate the evidence and develop a response to a complex problem.

Several UCLA patients or their families are suing Olympus for negligence and fraud in state court. Among them are Young and his parents.

Olympus declined to comment on the pending litigation. The company said it expresses sympathy to the patients who have experienced infections and to their families. We are taking this matter extremely seriously.

 
 
 
Dr. Trevor K. Johnson
Freshman Silent
link   seeder  Dr. Trevor K. Johnson    11 years ago

More information regarding the evolution of this previously almost invisible epidemic:

The Hospital Lurkers: Clostridium Difficile and Acinetobacter

Doctors have long been battling a group of six hospital-borne pathogens dubbed ESKAPE: Enterococcus, Staphylococcus, Klebsiella, Acinetobacter, Pseudomonas and Enterobacter. Now those six bugs are escaping antibiotics.

"These organisms were present in hospitals 20 years ago," said Dr. John Bartlett, chief of infectious diseases at Johns Hopkins University School of Medicine in Baltimore. "Now we've used so many antibiotics to treat them, they've been trained to become resistant."

The bacteria invade vulnerable bodies through hospital equipment, like surgical implants and central lines.

"When people come into the hospital, they often get metal put in them, or plastic lines. All of those foreign bodies [make someone] susceptible to infection," said Bartlett. "We can't help it. It's nobody's fault."

 
 
 
screminmimi
Freshman Silent
link   screminmimi    11 years ago

I'm shocked at this information; my daughter is a nurse and I've never heard either of anything being resistant to sterilization procedures.

When I was scheduled for surgery last year, just a couple of weeks prior to the procedure, I heard about a problem with robotic surgical instruments being contaminated and that these robots traveled around the country to different hospitals. One patient had become infected with a rare brain disease because of the instrument used on him being contaminated through its use on another patient.

 
 
 
sixpick
Professor Quiet
link   sixpick    11 years ago

Deadly 'superbugs' invade U.S. health care facilities

A USA TODAY review finds that deadly CRE bacteria are showing up in hospitals and other health care facilities across the country and there is virtually nothing to stop these "superbugs" at this point.

Continue Reading with video as well

 
 
 
Aeonpax
Freshman Silent
link   Aeonpax    11 years ago

Sounds a bit like MRSA. Scary.

 
 
 
sixpick
Professor Quiet
link   sixpick    11 years ago

Like the old saying, if you want to live a long life, keep on breathing as long as you can and in this case if you want to live a long life, stay out of the hospital as long as you can.

 
 
 
Sophia Descertes
Freshman Silent
link   Sophia Descertes    11 years ago

OMG! This is so scary! People getting sick go to the hospital for help, not to be infected with a virus that kills 50% of the people that catch it.

I'm so glad that I am in good health, because to be totally honest, hospitals scare the crap out of me.

 
 
 
Petey Coober
Freshman Silent
link   Petey Coober    11 years ago

I've heard that there is a similar problem due to colonoscopies . Doc , do you happen to have any info about those as a source of infections ?

 
 

Who is online





72 visitors